Authors : Dr. Ann Elizabeth John; Dr. Jyothi Hattiholi; Dr. Bhagyashri Patil; Dr. Gajanan S. Gaude; Dr. Gautam S.; Dr. Kirankumar Pujar; Dr. Guruprasad Antin; Dr. Ningappa Karalingannavar

Volume/Issue : Volume 10 - 2025, Issue 3 - March

Google Scholar : https://tinyurl.com/4jjphwrw

Scribd : https://tinyurl.com/mrr4rf63

DOI : https://doi.org/10.38124/ijisrt/25mar002

Note : A published paper may take 4-5 working days from the publication date to appear in PlumX Metrics, Semantic Scholar, and ResearchGate.

Abstract : Background Distinguishing between reactivation of pulmonary tuberculosis (TB) and interstitial lung disease (ILD) associated with connective tissue diseases poses a diagnostic challenge due to overlapping clinical and radiological features. This case highlights the complexities in differentiating these conditions and the need for a multidisciplinary approach.  Case Presentation An 18-year-old male, a farmer and a part time driver by occupation, presented with cough with expectoration, fever with chills and exertional breathlessness for 15 days. He had a history of incomplete antitubercular treatment therapy (ATT) initiated six months prior based on radiological suspicion of pulmonary TB. Examination revealed digital clubbing, calcinosis cutis and skin thickening of the upper extremities  Investigations: Chest Xray (CXR) and high resolution computed tomography (HRCT) of the thorax demonstrated fibrobronchiectatic and fibrocavitatory changes with diffuse lung involvement suggestive of active Koch'sinfection. However, sputum CBNAAT was negative and further autoimmune workup revealed a positive rheumatoid factor and strongly positive anti-SCL-70 antibodies indicative of an underlying connective tissue disease. Pulmonary function tests showed a restrictive pattern and echocardiography suggested mild pulmonary hypertension.  Management and Outcome The patient was initiated on antibiotics for infection control, antifibrotic therapy for ILD management and closely monitored for disease progression. The case underscores the necessity of comprehensive immunological and microbiological workup in patients with suspected TB, especially in endemic areas to avoid misdiagnosis and delayed intervention.  Conclusion: The overlap in clinical and radiological features between TB and connective tissue disease associated ILD necessitates a high index of suspicion and thorough diagnostic evaluation. Early differentiation is crucial to guide appropriate treatment and improve patient outcomes. A multidisciplinary approach, including pulmonologists, rheumatologists and infectious disease specialists, is essential in managing such diagnostic dilemmas.

Keywords : Pulmonary Tuberculosis, Interstitial Lung Disease, Connective Tissue Disease, Diagnostic Challenge, High Resolution CT, Autoimmune Screening.

References :

1. Akhter N, Rizvi NA. Interstitial lung diseases misdiagnosed as tuberculosis. Pak J Med Sci Q. 2018;34(2):338–41.
2. Arcana RI, Crișan-Dabija RA, Caba B, Zamfir A-S, Cernomaz TA, Zabara-Antal A, et al. Speaking of the “devil”: diagnostic errors in interstitial lung diseases. J Pers Med. 2023 Nov 10;13(11).
3. Ogawa K, Kurosaki A, Miyamoto A, Takahashi Y, Murase K, Hanada S, et al. Clinicoradiological Features of Pulmonary Tuberculosis with Interstitial Pneumonia. Intern Med. 2019 Sep 1;58(17):2443–9.
4. Park SW, Baek AR, Lee HL, Jeong SW, Yang SH, Kim YH, et al. Korean guidelines for diagnosis and management of interstitial lung diseases: part 1. introduction. Tuberc Respir Dis (Seoul). 2019 Oct;82(4):269–76.
5. Erre GL, Sebastiani M, Manfredi A, Gerratana E, Atzeni F, Passiu G, et al. Antifibrotic drugs in connective tissue disease-related interstitial lung disease (CTD-ILD): from mechanistic insights to therapeutic applications. Drugs Context. 2021 Jan 15;10.
6. Sambataro D, Sambataro G, Pignataro F, Zanframundo G, Codullo V, Fagone E, et al. Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them? Diagnostics (Basel). 2020 Apr 9;10(4).
7. Shen C-Y, Hsieh S-C, Yu C-L, Wang J-Y, Lee L-N, Yu C-J. Autoantibody prevalence in active tuberculosis: reactive or pathognomonic? BMJ Open. 2013 Jul 26;3(7).
8. Schoenfeld SR, Castelino FV. Interstitial lung disease in scleroderma. Rheum Dis Clin North Am. 2015 May;41(2):237–48.